Risk factor
Strong & resilient to price shocks
Profitability factor
Favourable price performance
About
Sichuan Kelun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company that manages the entire lifecycle of medicinal products, from research and development to manufacturing, distribution, and sales. Its diverse product portfolio includes intravenous (IV) solutions, various injectable medications (such as powders and small volume parenterals), oral dosage forms, key active pharmaceutical ingredients (APIs) and their intermediates, and specialized peritoneal dialysis solutions. Established in 1996, the company operates from its headquarters in Chengdu, People's Republic of China, and functions as a subsidiary of Sichuan Kelun Industry Group CO., LTD.
Company Valuation
Based on key historical and expected multiples, the stock is overvalued relative to its peers. In particular, the stock is overpriced on P/E, of fair value on EV/EBITDA,
Target Price
The average target price of 002422.SZ is 39 and suggests 1% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendatio